Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP726683.RA-a4-JDuvl25iMVkLEl_RSRuIIv1KuTf6tzOTpVgLEuY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP726683.RA-a4-JDuvl25iMVkLEl_RSRuIIv1KuTf6tzOTpVgLEuY130_assertion type Assertion NP726683.RA-a4-JDuvl25iMVkLEl_RSRuIIv1KuTf6tzOTpVgLEuY130_head.
- NP726683.RA-a4-JDuvl25iMVkLEl_RSRuIIv1KuTf6tzOTpVgLEuY130_assertion description "[Therefore, inhibition of Cripto-1 expression using blocking antibodies or antisense expression vectors might be a useful modality not only to target fully differentiated cancer cells but also to target a subpopulation of tumor cells with stem-like characteristics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP726683.RA-a4-JDuvl25iMVkLEl_RSRuIIv1KuTf6tzOTpVgLEuY130_provenance.
- NP726683.RA-a4-JDuvl25iMVkLEl_RSRuIIv1KuTf6tzOTpVgLEuY130_assertion evidence source_evidence_literature NP726683.RA-a4-JDuvl25iMVkLEl_RSRuIIv1KuTf6tzOTpVgLEuY130_provenance.
- NP726683.RA-a4-JDuvl25iMVkLEl_RSRuIIv1KuTf6tzOTpVgLEuY130_assertion SIO_000772 20624125 NP726683.RA-a4-JDuvl25iMVkLEl_RSRuIIv1KuTf6tzOTpVgLEuY130_provenance.
- NP726683.RA-a4-JDuvl25iMVkLEl_RSRuIIv1KuTf6tzOTpVgLEuY130_assertion wasDerivedFrom befree-20150227 NP726683.RA-a4-JDuvl25iMVkLEl_RSRuIIv1KuTf6tzOTpVgLEuY130_provenance.
- NP726683.RA-a4-JDuvl25iMVkLEl_RSRuIIv1KuTf6tzOTpVgLEuY130_assertion wasGeneratedBy ECO_0000203 NP726683.RA-a4-JDuvl25iMVkLEl_RSRuIIv1KuTf6tzOTpVgLEuY130_provenance.